本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Day One Biopharmaceuticals Inc.

7.22
-0.4900-6.36%
盤後7.390.1700+2.35%16:53 EDT
成交量:93.44萬
成交額:675.13萬
市值:7.32億
市盈率:-7.05
高:7.70
開:7.55
低:7.06
收:7.71
資料載入中...
2025/03/06

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2025/02/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/26

重要事件披露

Form 8-K - Current report
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/10

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/20

重要事件披露

Form 8-K - Current report
2024/11/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/31

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/30

重要事件披露

Form 8-K - Current report
2024/08/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/05

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/02

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]